DERIVATIVES OF 1,2,3-TRIAZOLYL CYCLOHEXAN-1-OL AND ITS USE

(19)

(11)

EP 3 303 319 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	11.03.2020 Bulletin 2020/11

(45)	Mention of the grant of the patent:
	11.12.2019 Bulletin 2019/50

(21)	Application number: 16738889.1

(22)	Date of filing: 07.06.2016

(51)

International Patent Classification (IPC):

C07D 401/06^(2006.01)

C07D 249/04^(2006.01)

(86)	International application number:
	PCT/PL2016/050026

(87)	International publication number:
	WO 2016/200283 (15.12.2016 Gazette 2016/50)

(54)	DERIVATIVES OF 1,2,3-TRIAZOLYL CYCLOHEXAN-1-OL AND ITS USE DERIVATE VON 1,2,3-TRIAZOLYL CYCLOHEXAN-1-OL UND DEREN VERWENDUNG DÉRIVÉS DE 1,2,3-TRIAZOLYLE CYCLOHEXAN-1-OL ET LEUR UTILISATION

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

08.06.2015 PL 41259415

(43)	Date of publication of application:
	11.04.2018 Bulletin 2018/15

(73)	Proprietor: Uniwersytet Jagiellonski
	31-007 Krakow (PL)

(72)	Inventors:
	KASZA, Patryk 43-100 Tychy (PL) CEGLA, Marek 30-638 Krakow (PL) SZAFRANSKI, Przemyslaw 41-500 Chorzow (PL)

(74)	Representative: BRANDPAT Patent and Trademark Attorneys Chlebicka Czyz Galazkiewicz Ziolkowski Professional Partnership
	Hoza 29/31 Apt.31 00-521 Warsaw 00-521 Warsaw (PL)

(56)

References cited: :

WO-A1-2009/038685

WO-A1-2012/021390

DATABASE REGISTRY [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 20 December 2013 (2013-12-20), XP002760498, retrieved from STN Database accession no. 1499628-29-3
GEORGE ACQUAAH-HARRISON ET AL: "Library of 1,4-Disubstituted 1,2,3-Triazole Analogs of Oxazolidinone RNA-Binding Agents", JOURNAL OF COMBINATORIAL CHEMISTRY., vol. 12, no. 4, 12 July 2010 (2010-07-12), pages 491-496, XP055293238, US ISSN: 1520-4766, DOI: 10.1021/cc100029y
ZHOU S ET AL: "Anisotropy studies of tRNA-T box antiterminator RNA complex in the presence of 1,4-disubstituted 1,2,3-triazoles", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 21, no. 23, 22 September 2011 (2011-09-22), pages 7059-7063, XP028334838, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2011.09.095 [retrieved on 2011-09-29]

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).